AAAAAA
Results:
1-11
|
Results: 11
Authors:
Lokich, J
Citation: J. Lokich, Oral fluoropyrimidines: Are they the equivalent of parenteral infusional 5-fluorouracil?, CANCER INV, 19(8), 2001, pp. 854-857
Authors:
Lokich, J
Citation: J. Lokich, What is the "best" platinum: Cisplatin, carboplatin, or oxaliplatin?, CANCER INV, 19(7), 2001, pp. 756-760
Authors:
Lokich, J
Citation: J. Lokich, Phase I clinical trial of weekly combined topotecan and irinotecan, AM J CL ONC, 24(4), 2001, pp. 336-340
Authors:
Mani, S
Hochster, H
Beck, T
Chevlen, EM
O'Rourke, MA
Weaver, CH
Bell, WN
White, R
McGuirt, C
Levin, J
Hohneker, J
Schilsky, RL
Lokich, J
Citation: S. Mani et al., Multicenter phase II study to evaluate a 28-day regimen of oral fluorouracil plus eniluracil in the treatment of patients with previously untreated metastatic colorectal cancer, J CL ONCOL, 18(15), 2000, pp. 2894-2901
Authors:
Lokich, J
Citation: J. Lokich, Phase I clinical trial of weekly combined paclitaxel plus docetaxel in patients with solid tumors, CANCER, 89(11), 2000, pp. 2309-2314
Authors:
Lokich, J
Citation: J. Lokich, 5-fluorouracil-induced small bowel toxicity in patients with colorectal carcinoma, CANCER, 88(10), 2000, pp. 2425-2426
Authors:
Lokich, J
Citation: J. Lokich, Doxil extravasation injury: A case report, ANN ONCOL, 10(6), 1999, pp. 735-736
Authors:
Anderson, N
Lokich, J
Moore, C
Bern, M
Coco, F
Citation: N. Anderson et al., A dose-escalation phase II clinical trial of infusional mitomycin C for 7 days in patients with advanced measurable colorectal cancer refractory or resistant to 5-fluorouracil, CANCER INV, 17(8), 1999, pp. 586-593
Authors:
Lokich, J
Citation: J. Lokich, Pharmacokinetic modulation of 5-fluorouracil: Emulating continuous infusion?, CANCER INV, 17(7), 1999, pp. 543-544
Authors:
Lokich, J
Citation: J. Lokich, Single-dose granulocyte colony-stimulating factor concomitant with multifractionated dose chemotherapy: A strategy for maintaining dose intensity, CANCER INV, 17(7), 1999, pp. 547-550
Authors:
Lokich, J
Citation: J. Lokich, Multifractionated dosing for cancer chemotherapy: A novel schedule and a work in progress, CANCER INV, 17(7), 1999, pp. 551-554
Risultati:
1-11
|